Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reunion Business Network.

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Herblain (France),...

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
Introduction The European Central Bank (ECB), with the support of the European System of Central Bank’s (ESCB’s) Statistics Committee, compiles and publishes the balance of payments (b.o.p.) and the international investment position (i.i.p.) of...

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation...

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion...

Ethanol Market Worth USD 163.9 Billion by 2032 at 4.9% CAGR
The Ethanol Market size is expected to be worth around USD 163.9 Bn by 2032 from USD 102.8 Bn in 2022, growing at a CAGR of 4.9% from 2022 to 2032. NEW YORK, NY, UNITED STATES, February 6, 2025 /EINPresswire.com/ -- The Ethanol Market is poised...

Statement on the Cabinet meeting of Wednesday, 17 September 2025
A. Issues in the environment 1. Economy 1.1. Economic Growth 1.1.1. Cabinet welcomed the latest GDP figures, which show that the economy has grown 0.8% in the second quarter of 2025, an improvement from the 0.1% growth in the first quarter. 1.1.2....

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA...
Convening of the Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 and evolution of the Atos Board of Directors
Communiqué de presse Convening of the Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 and evolution of the Atos Board of Directors Paris, France, December 19, 2024 Convening of Annual General Meeting...

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025
Programme Directors, Minister of Sport, Arts, and Culture, Mr. Gayton McKenzie and Deputy Minister of Sport, Arts and Culture, Ms. Peace Mabe; Honourable Ministers and Deputy Ministers present here today; Members of Parliament and Provincial...

Public Health Action Network Is A Partnering Organization for the 'Healthy Indoor Air' Event at the UN General Assembly
The Healthy Indoor Air event will bring together indoor air experts and policymakers from around the world. NEW YORK CITY, NY, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Public Health Action Network (PHAN), a nonprofit public health...

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four...

Bloomin' Blinds of BuxMont Is 2025 Franchise Owner of the Year at National Awards Event
Bloomin’ Blinds of BuxMont earns top franchise honors and national sales awards at 2025 Bloomin’ Blinds Family Reunion and Pink Party. SOUTHAMPTON, PA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- At the 2025 Bloomin’ Blinds Awards...

WHO cautions against increase of chikungunya illness
(MENAFN) The World Health Organization (WHO) has warned on Tuesday that without swift measures, the world risks facing a resurgence similar to the 2005 chikungunya outbreak. “Although chikungunya is not widely recognized, it is currently present...

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older...


Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a...

WHO cautions of increase of chikungunya disease
(MENAFN) The World Health Organization (WHO) cautioned on Tuesday that without swift measures, the world could face a repeat of the 2005 chikungunya outbreak. Diana Rojas Alvarez, WHO’s arbovirus team lead, revealed that the mosquito-borne virus...

WHO Cautions Chikungunya Spread Threatens Billions
(MENAFN) The World Health Organization (WHO) issued a stark warning Tuesday, cautioning that the world may be on the brink of reliving the devastating 2005 chikungunya epidemic unless swift containment measures are taken. "Chikungunya is not a...

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya...